In early October 2025, India was shaken by reports of twenty-three child deaths in Madhya Pradesh and Rajasthan linked to contaminated cough syrups. This tragedy, the country’s sixth recorded case of diethylene glycol (DEG) poisoning, exposed deep failures in medical prescription, pharmaceutical manufacturing, and regulatory oversight.
Investigations revealed that untested and unsafe medicines, negligence in quality checks, and weak enforcement of drug standards turned a preventable error into another national disaster. From doctors prescribing banned formulations to manufacturers bypassing safety testing and regulators denying contamination, every level of accountability failed.